GSK-3036656

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameGSK-3036656
Drug Alias NameGSK-656GSK-3036656
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeucyl-tRNA synthetase inhibitors
TargetsLeucyl-tRNA synthetase
Therapy Area/IndicationsTuberculosis, PulmonaryTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryVietnamUgandaTanzania +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsTuberculosis, PulmonaryTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A